Open in Screener

PACB

Pacific Biosciences of California Inc

Jun 22 • 04:00PM ET

1.32

-0.08 -5.71 %

Healthcare • Medical Devices • USA • Small • NASD

Peers: ILMN BIO BRKR TWST A QGEN WAT MTD DHR TMO

| Held by: ARKK ARKG VTI IWM VXF IWN IBB VTWO SCHA PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.43	Insider Own	7.80%	Shs Outstand	310.49M	Perf Week	0.76%
Market Cap	409.99M	Forward P/E	-	EPS next Y	-0.47	Insider Trans	-3.27%	Shs Float	286.36M	Perf Month	10.92%
Enterprise Value	837.40M	PEG	-	EPS next Q	-0.13	Inst Own	52.49%	Short Float	17.01%	Perf Quarter	-0.75%
Income	-128.58M	P/S	2.56	EPS this Y	77.47%	Inst Trans	-4.13%	Short Ratio	8.04	Perf Half Y	-31.61%
Sales	160.03M	P/B	173.23	EPS next Y	-14.15%	ROA	-15.65%	Short Interest	48.71M	Perf YTD	-29.41%
Book/sh	0.01	P/C	1.49	EPS next 5Y	39.45%	ROE	-273.55%	52W High	2.73 -51.65%	Perf Year	3.94%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	-9.18% -	ROIC	-18.23%	52W Low	1.09 21.10%	Perf 3Y	-89.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.64% 15.19%	Gross Margin	38.16%	Volatility	6.48% 8.41%	Perf 5Y	-95.64%
Dividend TTM	-	EV/Sales	5.23	EPS Y/Y TTM	81.29%	Oper. Margin	-87.67%	ATR (14)	0.11	Perf 10Y	-84.98%
Dividend Ex-Date	-	Quick Ratio	4.87	Sales Y/Y TTM	5.04%	Profit Margin	-80.34%	RSI (14)	44.37	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	5.65	EPS Q/Q	98.11%	SMA20	-5.92%	Beta	2.33	Target Price	2.46
Payout	-	Debt/Eq	296.79	Sales Q/Q	0.07%	SMA50	-8.78%	Rel Volume	0.75	Prev Close	1.40
Employees	485	LT Debt/Eq	296.67	Earnings	May 07 AMC	SMA200	-21.56%	Avg Volume	6.06M	Price	1.32
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	78.83% -6.92%	Trades		Volume	4,545,818	Change	-5.71%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20

Show Previous Ratings

Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com)
May-26-26 09:05AM	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing (GlobeNewswire)
May-21-26 04:05PM	PacBio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +5.04%
May-19-26 09:00AM	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology (Business Wire)
May-11-26 09:05AM	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss (GlobeNewswire)
08:30AM	Loading…
May-08-26 08:30AM	Pacific Biosciences of California, Inc. Q1 2026 Earnings Call Summary (Moby) -14.55%
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press)
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Loading…
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Loading…
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby)
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

PresidentMr. Christian O. Henry M.B.A.

CFO & Principal Accounting OfficerMr. James R. Gibson II

Chief Operating OfficerMr. Mark Van Oene Ph.D.

Co-FounderDr. Stephen Turner Ph.D.

Ph.D.Dr. Brett Atkins J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM

Open in Screener

MRNA

Moderna Inc

Jun 22 • 04:00PM ET

59.35

-4.61 -7.22 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: BNTX AMGN GILD REGN ALNY ARGX BIIB INCY VRTX BMRN

| Held by: VTI VOO VB IVV SPY VBR RSP IBB XLV CGGR

Index	S&P 500	P/E	-	EPS (ttm)	-8.15	Insider Own	8.44%	Shs Outstand	397.00M	Perf Week	18.90%
Market Cap	23.55B	Forward P/E	-	EPS next Y	-4.72	Insider Trans	-0.88%	Shs Float	363.29M	Perf Month	23.33%
Enterprise Value	19.64B	PEG	-	EPS next Q	-2.06	Inst Own	78.13%	Short Float	15.91%	Perf Quarter	15.50%
Income	-3.19B	P/S	10.58	EPS this Y	-18.38%	Inst Trans	1.07%	Short Ratio	8.38	Perf Half Y	94.51%
Sales	2.23B	P/B	3.18	EPS next Y	45.10%	ROA	-26.41%	Short Interest	57.81M	Perf YTD	101.24%
Book/sh	18.66	P/C	4.52	EPS next 5Y	26.32%	ROE	-36.56%	52W High	67.74 -12.39%	Perf Year	129.13%
Cash/sh	13.12	P/FCF	-	EPS past 3/5Y	- -29.93%	ROIC	-36.90%	52W Low	22.28 166.36%	Perf 3Y	-50.74%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-53.32% 19.33%	Gross Margin	11.55%	Volatility	11.29% 7.14%	Perf 5Y	-73.19%
Dividend TTM	-	EV/Sales	8.83	EPS Y/Y TTM	6.60%	Oper. Margin	-153.35%	ATR (14)	4.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.35	Sales Y/Y TTM	-29.97%	Profit Margin	-143.55%	RSI (14)	63.52	Recom	3.04
Dividend Gr. 3/5Y	- -	Current Ratio	2.41	EPS Q/Q	-35.16%	SMA20	17.56%	Beta	0.97	Target Price	47.05
Payout	-	Debt/Eq	0.18	Sales Q/Q	260.19%	SMA50	17.84%	Rel Volume	1.19	Prev Close	63.96
Employees	4700	LT Debt/Eq	0.17	Earnings	May 01 BMO	SMA200	50.64%	Avg Volume	6.90M	Price	59.35
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.53% 64.58%	Trades		Volume	8,362,788	Change	-7.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142

Show Previous Ratings

Jun-22-26 01:46PM	Moderna Stock's 6-Day Rally Ends in a Dive. Why It's One of the S&P 500's Biggest Losers Today. (Barrons.com) -7.22%
07:43AM	Modernas mRNA flu vaccine passes FDA AdCom, review underway (Pharmaceutical Technology)
Jun-18-26 05:45PM	MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine (Stocktwits)
05:30PM	?? Under the Radar: Moderna Stock Rises on Flu-Shot Recommendation (The Wall Street Journal)
04:23PM	FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine (The Wall Street Journal)
09:55AM	Loading…
09:55AM	Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA) (InvestorsHub)
Jun-17-26 07:00AM	Moderna to Host Investor Event - Science Day (ACCESSWIRE) +11.55%
Jun-16-26 05:54PM	MRNA Stock Surges As FDA Releases Positive Briefing Documents Ahead Of Key Vaccine Meeting (Stocktwits) +6.27%
12:48PM	Moderna Surges On This Surprising FDA View For Its mRNA-Based Flu Shot (Investor's Business Daily)
07:30AM	Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028 (ACCESSWIRE)
Jun-15-26 12:48AM	I worry deeply about bioterrorism: Is Europe sufficiently prepared for another pandemic? (Euronews)
Jun-10-26 07:06AM	Parabilis sets a record with a $670M biotech IPO (BioPharma Dive)
Jun-02-26 07:00AM	Moderna to Present at Upcoming Conference in June 2026 (ACCESSWIRE)
Jun-01-26 08:00AM	Moderna is developing an mRNA Ebola vaccine as a deadly outbreak spreads through Congo (Quartz)
08:00AM	Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting (ACCESSWIRE)
06:38AM	Loading…
06:38AM	Moderna Joins Global Initiative to Advance Vaccine Candidate for Bundibugyo Ebola Virus (MRNA) (InvestorsHub)
05:00AM	Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus (ACCESSWIRE)
May-28-26 04:27PM	JPMorgan says large-cap biotech is back as profits and pipelines fuel upside (Investing.com)
May-27-26 11:07AM	This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative. (Barrons.com)
May-26-26 06:16AM	Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine (BioPharma Dive)
May-21-26 12:45PM	MRNA Stock Slips: FDA Slates Advisory Hearing On Experimental Flu Shot (Stocktwits)
May-20-26 03:29PM	JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms (Investing.com) +5.25%
03:00PM	Roivant Sciences Ltd (ROIV) Q4 2025 Earnings Call Highlights: Strategic Settlements and ... (GuruFocus.com)
08:45AM	Roivant Shares Climb on Earnings Beat Despite Revenue Shortfall (ROIV) (InvestorsHub)
05:30AM	Biotech Investors Are Tuning Out the MAHA Chaos (The Wall Street Journal)
May-19-26 08:11AM	Nasdaq semis lead losses as bond yields put pressure on Iran talks (Proactive)
May-16-26 12:25AM	Hantavirus: Is there a risk of another pandemic? (Investing.com)
May-13-26 04:08AM	Why Moderna Is Still the Ultimate Stock Hedge Against Any Outbreak (Barrons.com) -5.35%
01:00AM	Money-Losing Moderna Is a Pandemic Hedge. What to Do With the Stock Now. (Barrons.com)
May-12-26 05:00PM	Moderna Recognized by TIME as One of the World's Most Impactful Companies (ACCESSWIRE)
04:22PM	Loading…
04:22PM	The Hantavirus Scare Brought 3 Covid-Era Stocks Back in the Spotlight (BeInCrypto)
12:01AM	Hantavirus Trade Stalls as Officials Say Risk to Public Ranges from Low to Very, Very Low (The Daily Upside)
May-11-26 02:00PM	Moderna Shares Have Rallied. Why the Stock Could Climb Another 30%. (Barrons.com)
01:17PM	Here's how much Moderna's stock has rallied off renewed focus on hantavirus research (MarketWatch)
12:15PM	Stock Market Today: Dow Steady After Trump Rejects Iran; Moderna Eyes Entry (Live Coverage) (Investor's Business Daily)
11:42AM	Moderna shares extend gains as hantavirus vaccine work draws attention (Proactive)
11:16AM	Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging. (Investopedia)
10:54AM	Memory chip stocks hit record highs, pharma reacts to hantavirus concerns (Yahoo Finance Video)
09:47AM	Stocks to Watch: Moderna, Intel, Micron, Fox (The Wall Street Journal)
08:12AM	Moderna stock extends gains on hantavirus research (Yahoo Finance)
08:04AM	S&P 500 set for muted open as Trump brands Iran offer 'totally unacceptable' (Proactive)
08:00AM	Moderna stock surges as hantavirus outbreak spotlights early vaccine work and flu data (Quartz)
07:53AM	Moderna stock surges on hantavirus vaccine, flu trial data (Quartz)
06:38AM	Moderna (MRNA) Shares Surge After U.S. Passenger Tests Positive for Hantavirus (InvestorsHub)
06:33AM	Trump Knows AI Matters More to Markets Than Iran. His China Trip Is Crucial. (Barrons.com)
06:15AM	These Stocks Are Today's Movers: Moderna, Micron, Intel, Apollo Global, and More (Barrons.com)
06:07AM	Moderna shares jump 8% after U.S. national tests positive for hantavirus (Investing.com)
05:29AM	Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive. (Barrons.com)
May-08-26 02:44PM	How Hantavirus Made Moderna a Must-Own Stock Again (Barrons.com) +11.97%
02:40PM	Moderna mRNA flu vaccine bests standard shot in peer-reviewed trial, FDA decision due in August (Quartz)
May-07-26 03:48PM	Moderna Stock Rallied on Hantavirus Fears. What to Know. (Barrons.com)
10:07AM	Moderna stock jumps 10% amid hantavirus outbreak concerns (Investing.com)
May-06-26 12:01AM	Cancer Treatments Propel Pfizer Sales Growth as Covid Revenue Dwindles (The Daily Upside)
May-05-26 12:30PM	Chicken or the Egg? Why We Need to Rethink Data and Funding in Startups (Entrepreneur)
May-02-26 03:00AM	Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges (GuruFocus.com)
May-01-26 04:49PM	Moderna, Inc. Q1 2026 Earnings Call Summary (Moby)
11:55AM	Moderna Sales Triple To $389 Million As Shares Rise 5.4% (GuruFocus.com)
11:53AM	Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on earnings (Proactive)
10:24AM	Moderna Beats Estimates on International Covid Shot Sales (The Wall Street Journal)
09:10AM	Moderna's revenue more than tripled in Q1, driven by international COVID vaccine sales (Quartz)
09:05AM	Moderna Q1 2026 earnings beat on international COVID vaccine sales (Quartz)
07:46AM	Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again. (Barrons.com)
07:17AM	Moderna beats revenue expectations despite wider loss (Investing.com)
06:49AM	Moderna: Q1 Earnings Snapshot (Associated Press)
06:37AM	Moderna Reports Higher Revenue but Posts a Loss (The Wall Street Journal)
06:30AM	Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates (ACCESSWIRE)
Apr-30-26 07:10PM	Stock market today: Dow, S&P 500, Nasdaq mixed but muted after record highs as earnings roll in (Yahoo Finance)
Apr-24-26 04:55PM	CureVac sues Moderna for patent infringement over COVID-19 vaccines (Reuters)
Apr-22-26 07:21AM	Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial (BioPharma Dive)
Apr-21-26 10:00AM	Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting (ACCESSWIRE)
09:40AM	Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 (ACCESSWIRE)
07:00AM	Moderna to Present at Upcoming Conferences in May 2026 (ACCESSWIRE)
Apr-17-26 11:30AM	Kailera makes history with record-breaking $625m IPO (Pharmaceutical Technology)
07:53AM	OpenAI is launching a specialized AI model for drug discovery and life sciences research (Quartz)
Apr-16-26 04:38PM	Kailera nets $625M in one of biotechs biggest-ever IPOs (BioPharma Dive)
Apr-15-26 07:00AM	Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026 (ACCESSWIRE)
Apr-13-26 06:00AM	OS Therapies Appoints Biotech Industry Luminary Robert "Bob" S. Langer, PhD as Strategic Advisor (TMX Newsfile)
Apr-08-26 12:58PM	Moderna eyes international markets as growth driver, says Bank of America (Proactive)
12:58PM	Bank of America flags international opportunities as key growth driver for Moderna (Proactive)
Apr-05-26 05:30AM	One of the Stock Market's Last Havens Is Now at Risk (The Wall Street Journal)
Mar-26-26 07:30AM	America is handing its mRNA lead to Chinaand RFK Jr. is to blame (Fortune)
Mar-24-26 07:51AM	S&P 500 Sinks Into Red -- These Seven Stocks Are Soaring Triple Digits (GuruFocus.com)
Mar-19-26 12:18PM	Xbow Raises $120 Million, Hits $1 Billion Valuation in AI Cybersecurity Push (GuruFocus.com)
Mar-17-26 08:06AM	Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They? (Investor's Business Daily)
Mar-16-26 04:03PM	Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves (Barrons.com)
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-13-26 07:54AM	GSKs RSV vaccine wins broader FDA clearance (BioPharma Dive)
Mar-10-26 11:01AM	Kohl's Q4 sales miss, EV maker NIO reports first quarterly profit (Yahoo Finance Video)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
08:19AM	BioNTechs Founding Duo Will Leave to Start New mRNA Firm (Bloomberg)
Mar-09-26 04:37PM	This biotech's stock soared after a 'polarizing' FDA official is stepping down (MarketWatch) +6.13%
01:32PM	What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? (Benzinga)
10:11AM	Stocks to Watch Monday: Boeing, Live Nation, Moderna, United Machines (The Wall Street Journal)
07:01AM	Why Is uniQure Stock Skyrocketing Monday? (Benzinga)
Mar-08-26 10:25PM	Corrections & Amplifications (The Wall Street Journal)
Mar-07-26 12:41AM	Controversial FDA Vaccines Chief Vinay Prasad To Leave Agency In April (Benzinga)
Mar-06-26 06:05PM	Moderna Pops As Vinay Prasad, The FDA's Controversial Vaccine Head, Will Depart In April (Investor's Business Daily) +6.13%
08:30AM	These 3 Stocks Just Bounced From Lows What Wall Street Thinks Comes Next (24/7 Wall St.)
Mar-05-26 12:33PM	Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit (Pharmaceutical Technology) -6.87%

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Technical Operations & Quality OfficerDr. Jerh Collins Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your Finviz experience